Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Cannabidiol displays antiangiogenic activity in preclinical tests

Aug. 10, 2010

BPR-0912 exhibits antiobesity effects in vivo

Aug. 9, 2010

Preclinical study implicates GPR55 in regulation of osteoclast number and function

Aug. 6, 2010

Scientists explore neuroprotective role of URB-597 in models of retinal neurodegeneration

Aug. 6, 2010

PF-3845 has antiallodynic effects in preclinical study

Aug. 6, 2010

TM-38837 shows favorable safety and pharmacokinetics in healthy subjects

Aug. 5, 2010

Japanese scientists identify potential biomarkers for coronary artery disease

Aug. 5, 2010

Candesartan inhibits fibrosis in rat model of RMI by suppressing sFRP-2

Aug. 5, 2010

TBR-652 exhibits potent anti-HIV activity in phase II trial

Aug. 4, 2010

Reduced TSPO expression and low progesterone are linked to MDD

Aug. 3, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...